- Home
- NMIH vs RXRX Comparison
NMIH vs RXRX Comparison
Compare NMIH & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMIH
- RXRX
- Stock Information
- Founded
- NMIH 2011
- RXRX 2013
- Country
- NMIH United States
- RXRX United States
- Employees
- NMIH N/A
- RXRX N/A
- Industry
- NMIH Property-Casualty Insurers
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- NMIH Finance
- RXRX Health Care
- Exchange
- NMIH Nasdaq
- RXRX Nasdaq
- Market Cap
- NMIH 2.8B
- RXRX 2.6B
- IPO Year
- NMIH 2013
- RXRX 2021
- Fundamental
- Price
- NMIH $37.88
- RXRX $4.33
- Analyst Decision
- NMIH Buy
- RXRX Buy
- Analyst Count
- NMIH 7
- RXRX 5
- Target Price
- NMIH $42.14
- RXRX $7.60
- AVG Volume (30 Days)
- NMIH 850.3K
- RXRX 22.3M
- Earning Date
- NMIH 04-29-2025
- RXRX 05-05-2025
- Dividend Yield
- NMIH N/A
- RXRX N/A
- EPS Growth
- NMIH 14.57
- RXRX N/A
- EPS
- NMIH 4.63
- RXRX N/A
- Revenue
- NMIH $667,964,000.00
- RXRX $59,790,000.00
- Revenue This Year
- NMIH N/A
- RXRX $57.30
- Revenue Next Year
- NMIH $5.10
- RXRX $51.53
- P/E Ratio
- NMIH $8.18
- RXRX N/A
- Revenue Growth
- NMIH 11.61
- RXRX 29.32
- 52 Week Low
- NMIH $31.59
- RXRX $3.79
- 52 Week High
- NMIH $42.49
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- NMIH 65.10
- RXRX 36.37
- Support Level
- NMIH $37.19
- RXRX $4.11
- Resistance Level
- NMIH $38.97
- RXRX $5.90
- Average True Range (ATR)
- NMIH 0.88
- RXRX 0.39
- MACD
- NMIH 0.49
- RXRX -0.11
- Stochastic Oscillator
- NMIH 81.47
- RXRX 11.00
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.